Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
Cadence Neuroscience Inc.
start up
United States
- Redmond, WA
- 18/05/2023
- Series B
- $26,000,000
Epilepsy treatment using a unique neuromodulation approach.
- Industry Medical Equipment Manufacturing
- Website https://www.cadenceneuro.com/
- LinkedIn https://www.linkedin.com/company/cadence-neuroscience-inc/
Related People
Kent LeydeFounder
United States -
Seattle, Washington
I am an experienced technologist, team builder, and leader. I have a track-record of creating work environments characterized by expectations of high performance, technical excellence, close collaboration, and meaningful peer review. I continue to be excited about opportunities to use technology to improve the human condition.
In addition to my role as a medical device developer, I provide NIH/NINDS with grant review assistance, and am a member of a local IRB overseeing clinical research.
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)